This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Aquanova Ag, Effrx Pharmaceuticals Sa. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: The Innovations of Marshall A. Hayward
Introduction
Marshall A. Hayward is an accomplished inventor based in Bridgewater, NJ (US). He holds 2 patents that showcase his contributions to the pharmaceutical field. His work focuses on innovative solutions for various medical conditions, demonstrating his commitment to advancing healthcare.
Latest Patents
One of Hayward's latest patents is a resveratrol solubilisation product for pharmaceutical purposes. This solubilisation product consists of resveratrol, polysorbate 80, polysorbate 20, at least one medium-chain triglyceride, and tocopherol. It is designed for use in treating Alzheimer's disease, Friedreich's ataxia, lysosomal diseases such as Tay-Sachs disease, cancer, diabetes, atherosclerosis, heart diseases, arthritis, and autoimmune diseases. Another significant patent is for stable effervescent bisphosphonate formulations with rapid solubilization characteristics. This invention includes a stable effervescent tablet, granule, or powder composition that is free from excipients that may react with an effervescing organic acid component. It comprises an effective amount of a bisphosphonate bone resorption inhibitor and has specific characteristics that ensure rapid solubilization in water.
Career Highlights
Throughout his career, Hayward has worked with notable companies such as Aquanova AG and EffRx Pharmaceuticals SA. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Hayward has collaborated with professionals like Dariush Behnam and Timo Schmidt, further enhancing his work in the field.
Conclusion
Marshall A. Hayward's contributions to pharmaceutical innovations reflect his dedication to improving healthcare solutions. His patents and collaborations highlight his significant role in advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile